Newsroom
Model Medicines Selected to Participate at the 5th Annual Evercore ISI HealthCONx Conference
November 29, 2022 • Boston, MA
Model Medicines to Present at Chem Together #4: Chemistry meets Artificial Intelligence
December 1, 2022 • Amsterdam Netherlands
Model Medicines to Present at Wells Fargo Private Biotech Symposium
November 2, 2022 • New York City
Model Medicines to Participate in the Berenberg Discover AI Seminar 2022
May 19 2022 ・San Francisco, CA
Model Medicines to Participate in the Truist Securities Life Sciences AI Symposium
March 1 2022 ・Virtual
Model Medicines to Participate The Virtual MedInvest Life Science Conference
September 8-10 2021 • Virtual
“AI and ML models... can significantly improve the efficacy of drug discovery.”
Arnab Chatterjee, Ph.D
Calibr at Scripps Research
“We are very pleased with the demonstrated potent antiviral activity of MDL-001.”
Davey Smith, MDUC
San Diego Health
“We are very excited to partner with Model Medicines on this important endeavor to identify novel therapeutics to treat the immediate threat of SARS-CoV-2 today and prepare for the pandemics of tomorrow.”
Sumit Chanda, Ph.D.
Sanford Burnham Prebys
“...a game-changer in the global fight against COVID-19.”
Adolfo Garcia-Sastre, Ph.D
Icahn School of Medicine at Mount Sinai